Stock Events

Stock Events

Newron Pharmaceuticals Spa. 

€17.6
0
+€1.5+9.32% Monday 14:23

Statistics

Day High
16.75
Day Low
16.25
52W High
33.75
52W Low
6.42
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24MarExpected
Q4 2025
-0.67
-0.63
-0.6
-0.57
Expected EPS
-0.56617019648
Actual EPS
-0.66727201728

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NP5.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap25.38B
Biogen Inc. focuses on discovering, developing, and delivering therapies for neurological and neurodegenerative diseases, directly competing with Newron's focus on central nervous system treatments.
Novartis
NVS
Mkt Cap297.35B
Novartis AG operates in the pharmaceuticals sector focusing on innovative medicines, including treatments for neurological conditions, making it a direct competitor.
Pfizer
PFE
Mkt Cap153.13B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including treatments for neurological disorders, competing in the same therapeutic areas as Newron.
Merck
MRK
Mkt Cap300.2B
Merck & Co., Inc. offers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products, including efforts in neurology and neurodegenerative diseases.
Lilly(Eli) &
LLY
Mkt Cap840.84B
Eli Lilly and Company is engaged in the discovery, development, and marketing of pharmaceutical products, with a strong focus on neuroscience, making it a competitor.
Rogers
ROG
Mkt Cap2.1B
Roche Holding AG focuses on pharmaceuticals and diagnostics with a strong emphasis on neuroscience, including multiple sclerosis and spinal muscular atrophy treatments.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap36.77B
Teva Pharmaceutical Industries Limited specializes in generic and specialty medicines, including CNS treatments, directly competing with Newron's product offerings.
Abbvie
ABBV
Mkt Cap367.8B
AbbVie Inc. focuses on pharmaceuticals including neuroscience, where it is developing treatments for several neurological conditions, competing with Newron.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, with its pharmaceutical segment developing treatments for neurological diseases.
Astrazeneca
AZN
Mkt Cap316.3B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including for neurological diseases, competing with Newron.

About

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company's lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. The company was founded in 1999 and is headquartered in Bresso, Italy.
Show more...
CEO
Mr. Stefan Weber
Employees
27
Country
Germany
ISIN
IT0004147952

Listings

STU
DE
NP5.STU
MU
DE
NP5.MU
XETRA
DE
NP5.XETRA
LSE
GB
0QOI.LSE

0 Comments

Share your thoughts

FAQ

What is Newron Pharmaceuticals Spa. stock price today?▼
The current price of NP5.MU is €17.6 EUR — it has increased by +9.32% in the past 24 hours. Watch Newron Pharmaceuticals Spa. stock price performance more closely on the chart.
What is Newron Pharmaceuticals Spa. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Newron Pharmaceuticals Spa. stocks are traded under the ticker NP5.MU.
Is Newron Pharmaceuticals Spa. stock price growing?▼
NP5.MU stock has risen by +6.67% compared to the previous week, the month change is a -2.76% fall, over the last year Newron Pharmaceuticals Spa. has showed a +145.3% increase.
When is the next Newron Pharmaceuticals Spa. earnings date?▼
Newron Pharmaceuticals Spa. is going to release the next earnings report on September 22, 2026.
What were Newron Pharmaceuticals Spa. earnings last quarter?▼
NP5.MU earnings for the last quarter are -0.67 EUR per share, whereas the estimation was -0.57 EUR resulting in a -17.86% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Newron Pharmaceuticals Spa. have?▼
As of April 14, 2026, the company has 27 employees.
In which sector is Newron Pharmaceuticals Spa. located?▼
Newron Pharmaceuticals Spa. operates in the Other sector.
When did Newron Pharmaceuticals Spa. complete a stock split?▼
Newron Pharmaceuticals Spa. has not had any recent stock splits.
Where is Newron Pharmaceuticals Spa. headquartered?▼
Newron Pharmaceuticals Spa. is headquartered in Bresso, Germany.